Longeveron Inc (LGVN): תחזית צמיחת רווח נקי למניה לשנה הבאה

Longeveron Inc. (LGVN) is battling revenue shortages and delisting risks while retaining its staff of biochemists through a stock option system. The consensus EPS growth forecast for the coming year helps filter out market noise, with the 19.10 value serving as the baseline metric. Innovations in tissue regeneration for Alzheimer's disease open prospects for achieving active longevity.

This indicator determines the long-term value vector through the percentage change in expected earnings per share for the next fiscal period. By analyzing analyst expectations for N+1 earnings dynamics, the investor assesses the consensus growth forecast for capital relative to current values. For Longeveron Inc. (LGVN), the volatility of this metric directly reflects regulatory risks and the uncertainty surrounding the outcomes of cell therapy clinical trials.